Quarterly report · Q3
4480.TEDINET S100PKF8
Period2022-01-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.5bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥10.9bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2021-01-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥1.2bn | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥670m | 2021-01-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.4bn | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥743m | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥671m | 2021-01-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.4bn | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥693m | 2021-01-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥957m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥563m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥442m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥956m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥435m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥21.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥20.2bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥22.0bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.5bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥6.2bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.8bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥14.0bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥15.6bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.3bn | at 2021-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥29.93 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.37 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.79 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.02 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.56 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥29.34 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥17.15 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥13.49 | 2021-01-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 68.9% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥1.7bn |
| jpcrp040300-q3r_E33586-000Medical Platform Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥2.5bn |
| jpcrp040300-q3r_E33586-000Medical Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥2.5bn |
| jpcrp040300-q3r_E33586-000Medical Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥410m |
| jpcrp040300-q3r_E33586-000New Business Development Servicesreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥244m |
| jpcrp040300-q3r_E33586-000New Business Development Servicesreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥244m |
| jpcrp040300-q3r_E33586-000New Business Development Servicesreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥44m |
| jpcrp040300-q3r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥7.7bn |
| jpcrp040300-q3r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥7.7bn |
| jpcrp040300-q3r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥1m |
| jpcrp040300-q3r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥3.4bn |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥10.5bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥10.5bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥1m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥3.0bn |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-09-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-09-30 | −¥1.4bn |
| jpcrp040300-q3r_E33586-000Medical Platform Businessreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥1.9bn |
| jpcrp040300-q3r_E33586-000Medical Platform Businessreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥1.9bn |
| jpcrp040300-q3r_E33586-000Medical Platform Businessreportable segment | segment profit | 2021-01-01 → 2021-09-30 | −¥378m |
| jpcrp040300-q3r_E33586-000New Business Development Servicesreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥212m |
| jpcrp040300-q3r_E33586-000New Business Development Servicesreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥212m |
| jpcrp040300-q3r_E33586-000New Business Development Servicesreportable segment | segment profit | 2021-01-01 → 2021-09-30 | −¥38m |
| jpcrp040300-q3r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥6.0bn |
| jpcrp040300-q3r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥6.0bn |
| jpcrp040300-q3r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥0 |
| jpcrp040300-q3r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥2.5bn |
| —segment total | revenue | 2021-01-01 → 2021-09-30 | ¥8.1bn |
| —segment total | revenue external | 2021-01-01 → 2021-09-30 | ¥8.1bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥0 |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥2.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 354
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |